Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > Long-Term Debt

Ampio Pharmaceuticals Long-Term Debt Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly Long-Term Debt from 2015 to 2015.
  • Ampio Pharmaceuticals Long-Term Debt for the quarter ending December 12, 2015 was $5m
  • Ampio Pharmaceuticals Long-Term Debt for the last 12 months ending December 12, 2015 was $5m
Other Cash Flow Metrics:
  • Ampio Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-3m a 19.89% decrease of -1m year over year
  • Ampio Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-3m a 68.32% decrease of -2m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE Long-Term Debt Data

12/2015$5m
09/2015$5m

Annual AMPE Long-Term Debt Data

2015$5m